Skip to main content

Table 1 Effect of SMI and / or DOX treatment on animal characteristics

From: Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators

GroupAscites (mL)First Body Weight (g)Final Body Weight (g)Heart Weight (g)HW/BW (mg/g)
Control0.00 ± 0.00#23.24 ± 1.9231.38 ± 1.57#0.14 ± 0.02#4.31 ± 0.49
DOX1.43 ± 0.32*23.15 ± 2.0826.17 ± 9.08*0.11 ± 0.03*4.06 ± 0.87
SM0.00 ± 0.00#23.02 ± 2.3631.12 ± 1.46#0.13 ± 0.01#4.28 ± 0.34
DOX + SMI(L)1.35 ± 0.30*23.09 ± 2.1626.47 ± 1.38*0.10 ± 0.01*3.61 ± 0.19*
DOX + SMI(M)0.89 ± 0.16*#23.49 ± 1.8825.80 ± 1.69*0.09 ± 0.01*3.65 ± 0.28*
DOX + SMI(H)0.00 ± 0.00#23.07 ± 2.3227.69 ± 1.78*#0.12 ± 0.02*4.22 ± 0.29
DOX + Aft-SMI(H)0.74 ± 0.62*#23.79 ± 2.2626.98 ± 2.67*0.10 ± 0.02*3.55 ± 0.41*#
  1. All values are mean ± S.D. (n = 10). *, significantly different (P < 0.05) from respective values in the control group. #, significantly different (P < 0.05) from respective values in the DOX group